Cargando…

Hemoglobin and mean platelet volume predicts diffuse T1-MRI white matter volume decrease in sickle cell disease patients

Sickle cell disease (SCD) is a life-threatening genetic condition. Patients suffer from chronic systemic and cerebral vascular disease that leads to early and cumulative neurological damage. Few studies have quantified the effects of this disease on brain morphometry and even fewer efforts have been...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Soyoung, Bush, Adam M., Borzage, Matthew T., Joshi, Anand A., Mack, William J., Coates, Thomas D., Leahy, Richard M., Wood, John C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5430155/
https://www.ncbi.nlm.nih.gov/pubmed/28540180
http://dx.doi.org/10.1016/j.nicl.2017.04.023
_version_ 1783236172784336896
author Choi, Soyoung
Bush, Adam M.
Borzage, Matthew T.
Joshi, Anand A.
Mack, William J.
Coates, Thomas D.
Leahy, Richard M.
Wood, John C.
author_facet Choi, Soyoung
Bush, Adam M.
Borzage, Matthew T.
Joshi, Anand A.
Mack, William J.
Coates, Thomas D.
Leahy, Richard M.
Wood, John C.
author_sort Choi, Soyoung
collection PubMed
description Sickle cell disease (SCD) is a life-threatening genetic condition. Patients suffer from chronic systemic and cerebral vascular disease that leads to early and cumulative neurological damage. Few studies have quantified the effects of this disease on brain morphometry and even fewer efforts have been devoted to older patients despite the progressive nature of the disease. This study quantifies global and regional brain volumes in adolescent and young adult patients with SCD and racially matched controls with the aim of distinguishing between age related changes associated with normal brain maturation and damage from sickle cell disease. T1 weighted images were acquired on 33 clinically asymptomatic SCD patients (age = 21.3 ± 7.8; F = 18, M = 15) and 32 racially matched control subjects (age = 24.4 ± 7.5; F = 22, M = 10). Exclusion criteria included pregnancy, previous overt stroke, acute chest, or pain crisis hospitalization within one month. All brain volume comparisons were corrected for age and sex. Globally, grey matter volume was not different but white matter volume was 8.1% lower (p = 0.0056) in the right hemisphere and 6.8% (p = 0.0068) in the left hemisphere in SCD patients compared with controls. Multivariate analysis retained hemoglobin (β = 0.33; p = 0.0036), sex (β = 0.35; p = 0.0017) and mean platelet volume (β = 0.27; p = 0.016) as significant factors in the final prediction model for white matter volume for a combined r(2) of 0.37 (p < 0.0001). Lower white matter volume was confined to phylogenetically younger brain regions in the anterior and middle cerebral artery distributions. Our findings suggest that there are diffuse white matter abnormalities in SCD patients, especially in the frontal, parietal and temporal lobes, that are associated with low hemoglobin levels and mean platelet volume. The pattern of brain loss suggests chronic microvascular insufficiency and tissue hypoxia as the causal mechanism. However, longitudinal studies of global and regional brain morphometry can help us give further insights on the pathophysiology of SCD in the brain.
format Online
Article
Text
id pubmed-5430155
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-54301552017-05-24 Hemoglobin and mean platelet volume predicts diffuse T1-MRI white matter volume decrease in sickle cell disease patients Choi, Soyoung Bush, Adam M. Borzage, Matthew T. Joshi, Anand A. Mack, William J. Coates, Thomas D. Leahy, Richard M. Wood, John C. Neuroimage Clin Regular Article Sickle cell disease (SCD) is a life-threatening genetic condition. Patients suffer from chronic systemic and cerebral vascular disease that leads to early and cumulative neurological damage. Few studies have quantified the effects of this disease on brain morphometry and even fewer efforts have been devoted to older patients despite the progressive nature of the disease. This study quantifies global and regional brain volumes in adolescent and young adult patients with SCD and racially matched controls with the aim of distinguishing between age related changes associated with normal brain maturation and damage from sickle cell disease. T1 weighted images were acquired on 33 clinically asymptomatic SCD patients (age = 21.3 ± 7.8; F = 18, M = 15) and 32 racially matched control subjects (age = 24.4 ± 7.5; F = 22, M = 10). Exclusion criteria included pregnancy, previous overt stroke, acute chest, or pain crisis hospitalization within one month. All brain volume comparisons were corrected for age and sex. Globally, grey matter volume was not different but white matter volume was 8.1% lower (p = 0.0056) in the right hemisphere and 6.8% (p = 0.0068) in the left hemisphere in SCD patients compared with controls. Multivariate analysis retained hemoglobin (β = 0.33; p = 0.0036), sex (β = 0.35; p = 0.0017) and mean platelet volume (β = 0.27; p = 0.016) as significant factors in the final prediction model for white matter volume for a combined r(2) of 0.37 (p < 0.0001). Lower white matter volume was confined to phylogenetically younger brain regions in the anterior and middle cerebral artery distributions. Our findings suggest that there are diffuse white matter abnormalities in SCD patients, especially in the frontal, parietal and temporal lobes, that are associated with low hemoglobin levels and mean platelet volume. The pattern of brain loss suggests chronic microvascular insufficiency and tissue hypoxia as the causal mechanism. However, longitudinal studies of global and regional brain morphometry can help us give further insights on the pathophysiology of SCD in the brain. Elsevier 2017-04-29 /pmc/articles/PMC5430155/ /pubmed/28540180 http://dx.doi.org/10.1016/j.nicl.2017.04.023 Text en © 2017 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Regular Article
Choi, Soyoung
Bush, Adam M.
Borzage, Matthew T.
Joshi, Anand A.
Mack, William J.
Coates, Thomas D.
Leahy, Richard M.
Wood, John C.
Hemoglobin and mean platelet volume predicts diffuse T1-MRI white matter volume decrease in sickle cell disease patients
title Hemoglobin and mean platelet volume predicts diffuse T1-MRI white matter volume decrease in sickle cell disease patients
title_full Hemoglobin and mean platelet volume predicts diffuse T1-MRI white matter volume decrease in sickle cell disease patients
title_fullStr Hemoglobin and mean platelet volume predicts diffuse T1-MRI white matter volume decrease in sickle cell disease patients
title_full_unstemmed Hemoglobin and mean platelet volume predicts diffuse T1-MRI white matter volume decrease in sickle cell disease patients
title_short Hemoglobin and mean platelet volume predicts diffuse T1-MRI white matter volume decrease in sickle cell disease patients
title_sort hemoglobin and mean platelet volume predicts diffuse t1-mri white matter volume decrease in sickle cell disease patients
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5430155/
https://www.ncbi.nlm.nih.gov/pubmed/28540180
http://dx.doi.org/10.1016/j.nicl.2017.04.023
work_keys_str_mv AT choisoyoung hemoglobinandmeanplateletvolumepredictsdiffuset1mriwhitemattervolumedecreaseinsicklecelldiseasepatients
AT bushadamm hemoglobinandmeanplateletvolumepredictsdiffuset1mriwhitemattervolumedecreaseinsicklecelldiseasepatients
AT borzagematthewt hemoglobinandmeanplateletvolumepredictsdiffuset1mriwhitemattervolumedecreaseinsicklecelldiseasepatients
AT joshiananda hemoglobinandmeanplateletvolumepredictsdiffuset1mriwhitemattervolumedecreaseinsicklecelldiseasepatients
AT mackwilliamj hemoglobinandmeanplateletvolumepredictsdiffuset1mriwhitemattervolumedecreaseinsicklecelldiseasepatients
AT coatesthomasd hemoglobinandmeanplateletvolumepredictsdiffuset1mriwhitemattervolumedecreaseinsicklecelldiseasepatients
AT leahyrichardm hemoglobinandmeanplateletvolumepredictsdiffuset1mriwhitemattervolumedecreaseinsicklecelldiseasepatients
AT woodjohnc hemoglobinandmeanplateletvolumepredictsdiffuset1mriwhitemattervolumedecreaseinsicklecelldiseasepatients